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Abstract
Background: Brief measures of health-related quality of life (HRQOL) that assess both patient-reported functioning
and well-being after stroke are scarce. The objective of this study was to examine reliability and validity of one of these
measures, the patient-reported Quality of Life after Brain Injury–Overall Scale (QOLIBRI-OS), in patients after stroke.
Methods: Stroke survivors were examined prospectively using survey methods.
Core survey data (n = 125) and retest data (n = 36) were obtained at 3 and 12 months, respectively. Item properties
(distribution, floor and ceiling effects), psychometric properties (reliability and model fit), and validity (correlations with
established measures of anxiety, depression and HRQOL) of the QOLIBRI-OS were examined.
Results: Missing responses on the questionnaire were low (0.5%). All items were positively skewed. No floor effects
were present, whereas five out of six items showed ceiling effects. The summary QOLIBRI-OS score exhibited no floor
or ceiling effects, and had excellent internal consistency (Cronbach’s α =0.93). All item-total correlations were high (0.
73–0.88). The test-retest reliability of single items varied from 0.74 to 0.91 and was 0.93 for the overall score. The
confirmatory factor analysis yielded an excellent fit for a five-item version and provided tentative support for the
original six-item version. The convergent validity correlations were in the hypothesized directions, thus supporting the
construct validity.
Conclusions: The brief QOLIBRI-OS is a valid and reliable brief health-related outcome measure that is appropriate for
screening HRQOL in patients after stroke.
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Background
Strokes are associated with complex physical, cognitive
and psychosocial consequences that pose challenges to
valid long-term outcome assessments [1, 2]. Due to a
combination of functional, psychological and social con-
straints, the use of patients reported outcomes (PROs)
to assess progress following treatment is advocated [3,
4]. PROs also seek to ascertain patients’ views of the se-
verity of their symptoms and functional status [5].
Generic and disease-specific health related quality of life
(HRQOL) instruments assess consequences of health con-
ditions on quality of life comprising psychological, phys-
ical, social and daily-life domains [6]. Both generic and
disease-specific scales are used following stroke [7–9].
A comprehensive evaluation of the available HRQOL
measures found that generic scales had limited value
due to their lack of specificity to particular conditions
and low responsiveness to change [7]. In the past dec-
ade, the use of stroke-specific scales has increased [10].
Stroke-specific HRQOL measures should ideally be reli-
able, valid, responsive, precise and appropriate as well as
feasible, interpretable and easy to complete [3, 11–13]. Ex-
amples of these types of measures are the Stroke-Specific
Quality of Life (SS-QOL) scale [14] and the Stroke Impact
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Scale (SIS) [15], which both have shown good psychomet-
ric properties and been translated into several languages
[16–18]. Although these scales adequately assess func-
tional problems post-stroke, their comprehensive ap-
proach, i.e., inclusion of a large number of items covering
multiple domains, reduce their feasibility in research and
clinical use, especially for patients with cognitive deficits
[19] or fatigue post-stroke [20]. A brief HRQOL measure
could be useful for screening or in situations where the
workload should be minimal. Additionally, a brief
disease-specific version of the SIS with eight items has
been developed [21], but this index does not address satis-
faction, subjective functioning and subjective health status.
Moreover, to compare conditions between patients with
different disorders the measure has to be validated for use
in several diagnostic groups.
In literature search of a suitable brief instrument asses-
sing well-being, according to patient-reported satisfaction
and important functional domains following stroke, the
short Quality of Life after Brain injury Overall Scale
(QOLIBRI-OS) [22] was identified as a possible option.
This instrument was cross-culturally developed in six
European countries between 2000 and 2010, and validated
in more than 2000 patients after traumatic brain injury
(TBI) [23].
The QOLIBRI-OS is a brief TBI-specific HRQOL
index that addresses wellbeing and functioning [22].
The psychometric properties for the QOLIBRI-OS
after TBI are satisfactory to good and are highly cor-
related with the 37 QOLIBRI scale (six subscales), in-
dicating that a comparable construct is assessed [22].
The six items of the QOLIBRI-OS assess overall satis-
faction with physical function, cognition, emotional
status, ability to perform daily activities, personal life
and social relationships, and satisfaction with the
current situation and future prospects. A confirmatory
factor analysis of the scale seem to support
uni-dimensionality; however with some reservations as
absolute fit seems clearly poorer (i.e., RMSEA = .07)
than the relative fit (e.g., CFI = .98) [22]. QOLIBRI-OS
has also been validated for patients with aneurysmal
subarachnoid haemorrhage [24].
Stroke has important cognitive, emotional and physical
clinical consequences that are similar to those of TBI,
even though the health conditions differ in pathogenesis
[25, 26]. Thus, the aim of this study was to investigate
whether the QOLIBRI-OS is uni-dimensional and a reli-
able and valid measure of HRQOL post-stroke. To in-
vestigate its construct validity, we hypothesized positive
correlations between the QOLIBRI-OS and the other
HRQOL measures and negative correlations between the
QOLIBRI-OS and psychological distress. In addition,
concurrent relations of the individual QOLIBRI-items
with relevant measures were explored.
Methods
This validation study is a part of a larger stroke study
consecutively enrolling all patients, who were admitted
to the stroke units of the University Hospital of North-
ern Norway (UNN) between March 2014 and December
2014.The inclusion criteria were in accordance with
those of the National Stroke Registry. The exclusion cri-
teria were age below 18 years, residence outside the hos-
pital’s region or foreign nationality. Patients with stroke
related to brain malignancy, brain trauma or subarachnoid
haemorrhage were excluded. A few patients who received
acute stroke care in wards other than stroke units, due to
the presence of other serious diseases, were also excluded.
In total, 161 of 214 eligible patients with ischaemic or
haemorrhagic stroke (ICD10 codes I.61 and I.63) con-
sented to participate in the validation study, and 125 fi-
nally answered the questionnaire. While the response rate
for eligible patients was 56%, the response rate for in-
cluded consenting patients at 3 months was.
125 /161 = 78%. The flowchart in Fig. 1 shows more
information on patient enrolment.
The study was approved by the Norwegian Regional
Committee for Medical and Health Research Ethics
(2013/ 1472).
Data collection
Patients were recruited during hospitalization in the
stroke unit or by telephone within 3 months of dis-
charge. Participants were asked to provide written con-
sent. A local coordinator at all participating hospitals
distributed the questionnaires by mail. Self-reported data
were collected 3 months after stroke. Incomplete ques-
tionnaires were completed by filling in all missing items
after an additional telephone interview. When up to two
responses on any questionnaire were missing, mean im-
putation was performed. Questionnaires with more than
2 missing data points were excluded. Test-retest analysis
of the QOLIBRI-OS was performed at 12-month
follow-up due to the expected stability in functioning
post-stroke [27] at this time point. The first 40 partici-
pants who answered at 12 months were asked to
complete the retest in a 7- to 12-day period. Of these, 36
participants completed and returned the QOLIBRI-OS
within the timeframe, which provides a response-rate of
90%. We conducted statistical tests (e.g., Student t- and
chi-square tests) comparing the retest group (n = 36)
with those not retested (n = 89), but no significant differ-
ences in any demographic characteristics or stroke sever-
ity emerged.
Demographic and stroke registry data
Information about age, gender, living condition and stroke
was collected from the Norwegian Stroke Registry. Ques-
tions regarding education, marital status and work status
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were included in the mailed questionnaires, or were col-
lected from the medical records after consent. Function
was assessed with the Modified Rankin scale (MRS) [28], a
clinician-reported measure of global disability widely used
to evaluate post-stroke outcomes [28]. The scale consists of
six categories assessing the level of independence, ranging
from independent to bedridden or death. There is extensive
evidence on the validity of the MRS [28]. In our study, the
MRS was registered at 3 months after telephone interviews,
as part of the national stroke registry registration.
Participants
Sociodemographic and clinical characteristics of the 125
participants are shown in Table 1. The average age was
70.5 years, and 62% were male. Approximately 50% of
patients had less than 11 years of education, and three
out of four had retired before stroke.
At 3 months after stroke approximately 75% lived at
home without personal assistance. Compared to those
who did not respond (n = 36), participants were 5 years
younger and a larger proportion lived at home at 3
months. The participants and non-responders differed
statistically significantly in age, MRS score at 3 months,
and proportion living in an institution and in need of
assistance. Gender and stroke subtypes were similar in
both groups (Table 1).
Comparisons between participants and patients that
were eligible for the validation study, but did not partici-
pate, were performed only for age and gender for ethical
reasons. However, there were no statistically significant
Fig. 1 Flowchart of persons with acute ischemic or hemorrhagic stroke registered during the recruiting period
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differences in these demographic data between the par-
ticipants and the patients who refused to participate or
between those who, due to a administrate failure, were
not contacted.
Measurements
The QOLIBRI-OS comprises six items that assess the
degree of overall satisfaction with “Physical Condition”,
“Cognition”, “Emotions”, “Ability to Perform Daily
Activities”, “Personal and Social Life,” and “Current
Situation and Future Prospects”. A Likert scale provides
the following five response categories: not at all (score 1),
slightly (score 2) moderately (score 3), quite (score 4), very
(score 5) for each item [22]. Accordingly, item score range
is 1–5 and sum score range 6–30.
Von Steinbuchel et al. [22] arithmetically converted
the sum of all items to a percentage scale (0–100). In
the present study, both the raw item scores and the
overall sum score were used. The QOLIBRI-OS has
demonstrated good internal consistency with a Cron-
bach’s α value of 0.86 in patients after TBI [22] and
0.88 in patients with subarachnoid haemorrhage. [24].
The QOLIBRI full scale (37 items) questionnaire has
been examined in a Norwegian study of patients after
TBI and showed metric properties supporting the reli-
ability and factor structure. To date, the QOLIBRI-OS
(6 items) has not been validated in Norwegian
samples. The QOLIBRI-OS was translated into Nor-
wegian in 2008 in accordance with recommended
procedures and is used in a longitudinal international
observational study (the European Union Study
CENTER-TBI-HEALTH. 2013.2.2.1–1). [29, 30] The
translation used in our study was slightly modified to
improve language fluency, and checked with back
translation by a professional translation service. Ac-
cording to a bilingual professional translator the se-
mantic meaning in our Norwegian version express the
meaning of the original English version.






Age at time of stroke, Mean (SD) 70.5 (13.1) 75 (13.6) < 0.05
Gender, n (%)
Female 48 (38) 16 (44)
Male 77 (62) 20 (56) 0.34
Stroke subtype, n (%)
Ischaemic 113 (90) 31 (86)
Haemorrhagic 12 (10) 5 (14) 0.33
Marital status at time of stroke, n (%)
Married/cohabitant 80 (64) 16 (45)
Widowed/single 45 (36) 20 (55) < 0.05
Education, time of stroke, n (%)
≤ 10 years (y) 60 (48) –
> 10 62 (50) – –
Unknown 3 (2) –
Living conditions at 3 months, n (%)
Home, without assistance 92 (73) 12 (33)
Home, with assistance 23 (19) 14 (39) < 0.01a
Institution/residence for the elderly 10 (8) 10 (28)
Work status at 3 months, n (%)
Student/Unemployed/Working fulltime or part-time 23 (18) 3 (8) 0.77
Retired/ Sick-leave 102 (82) 33 (92)
MRS at 3 months, n (%)
0–1 no symptoms or significant disability 84 (67) 15 (42)
2–3 slight or moderate disability 33 (26) 16 (44)
4–5 severe disability 8 (7) 7 (14) < 0.05b
aSignificantly more responders than non-responders lived at home without assistance vs. at home with assistance/in institution at 3 months after stroke
bWilcoxon signed rank test
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The Hospital Anxiety and Depression Scale (HADS), ori-
ginally published by Zigmond and Snaith in 1983 [31], is a
widely used instrument that screens for non-vegetative
symptoms of anxiety (seven items) and depression (seven
items) [32]. The HADS items are scored from 0 to 3 with
higher scores indicating worse symptoms. A cut-off score
of 8 indicates a possible diagnosis of anxiety or depression
[33]. The total score (HADS-14) can also be used as a glo-
bal measure of psychological distress [34]. The HADS ques-
tionnaire has been applied several times in Norwegian
populations [29], also post-stroke [35].
The EuroQol Five Dimensions Questionnaire (EQ-5D)
[36] is a three-level generic HRQOL questionnaire com-
prising 5 items measuring the dimensions of mobility,
self-care, ability to perform daily activities, pain/discom-
fort and anxiety and depression [37]. The levels are rated
as 1, 2, or 3, indicating no (1), some (2), and consider-
able problems (3). Each dimension can be scored separ-
ately. The questionnaire includes the EuroQol Visual
analogue Scale.
(EQ-VAS), which is a 0–100 visual analogue scale
intended to measure actual self-reported health status
from worst to best imaginable health [38].
The Stroke Specific Quality of Life (SS-QOL) scale
[14] assesses the functional impact of stroke across 12
domains using 49 items and a five-point Likert scale
where higher scores indicate better functioning. The
SS-QOL measures energy, mood, family roles, language,
mobility, self-care, social roles, thinking, personality, and
upper extremity function, vision and work/ productivity.
A sum score can be extracted from each domain. Separ-
ate domain scores are obtained from unweighted average
of all items belonging to a particular domain, but the
overall SS-QOL score is most often used as the primary
outcome. The SS-QOL scale has recently been trans-
lated into Norwegian in accordance with recommended
procedures [39, 40].
Validation study design
The construct and criterion-related validity of the
QOLIBRI-OS were examined in a confirmatory factor
analysis and as concurrent correlations with theoretically
related measures, respectively.The instruments chosen
represent different aspects like stroke specific health re-
lated functions in HRQOL-measures, generic health re-
lated quality of life instruments, single questions and
instruments assessing anxiety and depression. Moreover,
the criterion-related measures included in our study are
validated in Norwegian samples.The convergent and di-
vergent validity of the QOLIBRI-OS, as one specific type
of criterion-related validity, were supported if the Spear-
man rank-order correlations with the HADS total and
anxiety scales were negative and the EQ-5D and
SS-QOL were positive. Such correlations were calculated
for both the QOLIBRI-OS total and item scores. The
direction of these a priori hypothesised correlations were
based on the literature review in the introduction. Ac-
cording to the COSMIN guidelines [41], the overall con-
struct validity is rated positively if the hypothesized
relationships are specified in advance and supported in
at least 75% of the reported results and based on a mini-
mum of 50 patients.
Correlations above 0.50, between 0.31 and 0.49 and less
than 0.30 were considered high, moderate and low, respect-
ively [42]. Based on the literature review, we expected mod-
erate to strong correlations between the QOLIBRI-OS and
the criterion measures (see Table 2).The psychometric re-
sults from the current study were also used to re-evaluate
the content validity of the QOLIBRI-OS, and discuss
improvements.
Statistical and psychometric analyses
The Consensus-based Standards for the Selection of
Health Measurement Instruments (COSMIN) guidelines
[41] were used as guidelines for this validation study. The
psychometric classical test theory analyses were con-
ducted in Mplus version 7.4 [43] whereas all other infer-
ential analyses were conducted in IBM SPSS version 23.
Descriptive characteristics
The QOLIBRI-OS items were described in terms of
means and distributional properties. The degree of floor
and ceiling effects, as defined by more than 15% of re-
sponses in the extreme lower or upper categories of the
scale, were reported [44].
Uni-dimensionality
A confirmatory factor analysis was conducted to exam-
ine the fit of the QOLIBRI-OS as a uni-dimensional
model. The maximum likelihood with robust standard
errors (MLR) was applied, as the item distributions were
non-normal. Model fit was evaluated in terms of the
root mean square error of approximation (RMSEA), the
standardized root mean square residual (SRMR), the
comparative fit index (CFI) and the non-normed fit
index (NNFI) [45]. West et al. [45] suggest that RMSEA
< 0.05, CFI > 0.95, NNFI > 0.90 and SRMR < 0.06 repre-
sent a well-fitting model, while CFI > 0.90, NNFI > 0.85,
RMSEA < 0.08, and SRMR < 0.10 indicate a tentatively
adequate model.
Reliability
Cronbach’s α was used to investigate the internal
consistency. A value larger than 0.70 is generally recom-
mended for research purposes (e.g., group comparisons),
whereas values above 0.90 is desirable for individual clin-
ical assessment [46]. Correlations between QOLIBRI-OS
items and its total score were examined (values > 0.40 are
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preferable) [44] to identify items contributing poorly to
the reliability or the ranking of the patients. Test-retest
reliability was evaluated with intra-class correlation coeffi-
cients (ICCs) based on a two-way mixed model (i.e., treat-
ing items and subjects as fixed and random components,
respectively). Both ICC absolute agreement and ICC
consistency estimates were extracted for comparison pur-
poses [47]. ICC consistency values > 0.75 was considered
as excellent.
Results
Item characteristics and data quality of the QOLIBRI-OS
The degree of missing QOLIBRI-OS data was below
0.5% (Table 3). Single items were moderately positively
skewed. The QOLIBRI-OS total score did not show floor
or ceiling effects according to the COSMIN criterion we
used, whereas a modest ceiling effect (defined as > 15%)
was observed in all items with the exception of one
(“Physical condition”). All items robustly contributed to
the overall QOLIBRI score, with all item-total correla-
tions above 0.4 (ranging between 0.73–0.88).
Confirmatory factor analysis (CFA) of the QOLIBRI-OS
The model fit indicators of the hypothesized one-factor
model were not universally good (robust χ2df = 9 = 21.83,
p = 0.009). Although the relative fit indices were
good (CFI = 0.972 and NNFI = 0.953), the important
non-centrality index (RMSEA = 0.107) was poorer as
opposed to the absolute difference in unexplained
standardized residuals that were low (SRMR = 0.029).
This model thus yielded mixed support. Removing a
single item, i.e., item 3 (“Overall, how satisfied are you
with your feelings and emotions?”), yielded a model with
excellent universal fit (robust χ2df = 5 = 3.47, p = 0.63;
RMSEA = 0; SRMR = 0.015; CFI = 1.0; NNFI = 1.0).
As shown in Table 3, the ICC of the individual
QOLIBRI-OS items were high and ranged from 0.75 to
0.91, whereas the overall score had excellent stability,
ICC = 0.93.
Internal consistency of the QOLIBRI-OS overall score
was excellent (Cronbach’s α = 0.93). We also calculated
Cronbach’s α after removing the item “feelings and
emotions”.
to observe changes in the internal consistency. In the
resulting five-item scale, the Cronbach’s α declined from
0.93 to 0.90.
Construct validity
As the results of the CFA were mixed, and as the au-
thors considered the item in question (item 3) important
for evaluations of HRQOL after stroke, additional correl-
ation analyses were performed. First, the correlation be-
tween the five-item (after removing item 3) and six-item
overall QOLIBRI-OS was 0.99. Second, the correlations
between the HADS, EQ-VAS and the SS-QOL, and the
five-and six-item QOLIBRI-OS yielded almost identical
results.
Discussion
The results of this study indicated that the QOLIBRI-OS
had excellent internal consistency, with slightly higher
values than those reported in comparable studies after TBI
and subarachnoid haemorrhage [22, 24]. All item-total cor-
relations were high, and the items thus significantly con-
tributed to a reliable ranking of patients. According to the
COSMIN guidelines, floor and ceiling effects should not
Table 2 Construct validity of the QOLIBRI-OS at 3 months after stroke
Items Measure for comparison Correlation hypotheses Spearman’s Rho
1 Physical condition SS-QOL sum mobility High 0.44a
EQ5D mobility Moderate 0.31a
2 Cognitive function SS-QOL sum thinking Moderate to high 0.65a
3 Emotions SS-QOL sum mood High 0.66a
HADS-total score Moderate to high, negative −.0.70a
4 Daily activities SS-QOL sum work Moderate to high 0.62a
EQ5D Usual activities High 0.64a
5 Personal and social life SS-QOL sum social role Moderate 0.55a
HADS total score Moderate, negative −0.61a
6 Current situation and future prospects EQ VAS score High 0.57a
HADS anxiety scale High, negative −0.58a
Sum QOLIBRI-OS HADS total score High, negative −0.74a
EQ VAS score Moderate 0.56a
SS-QOL sum score High 0.71a
EQ5D EuroQol Quality of Life Scale-5D, HADS Hospital Anxiety and Depression Scale, SS-QOL Stroke-Specific Quality of Life Scale
aCorrelation is significant at the 0.01 level (two-tailed)
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exceed 15% [41]. In our study population, the summary
QOLIBRI-OS score had no floor or ceiling effects. Modest
ceiling effects were observed for the individual items.
Stroke populations are very heterogeneous, thus these ceil-
ing effects are difficult to interpret. For instance, certain
subgroups are expected to experience few or no cognitive
symptoms [48], therefore, the 20% of persons in this study
reporting optimal satisfaction with cognitive functioning
(item 2) did not necessarily indicate a problem with the
scale, but might rather represent a clinical feature of this
population [19]. No other studies have specifically investi-
gated ceiling effects for single items in the QOLIBRI-OS,
but von Steinbuchel et al. [22] reported a positive skew for
all items indicating positive HRQOL in patients with TBI.
The uni-dimensionality of the QOLOBRI-OS received
mixed support, as reported by others [49]. Muehlan et
al. [49] identified item 5 (personal and social life) as a
potentially problematic item after TBI. In the present
study the cause of the mixed fit was related to another
item (item 3: feelings and emotions). Removing this item
led to an excellent model fit for the resulting five-item
QOLIBRI-OS. Nevertheless, we retained all items in the
final model because the differences in the validity corre-
lations between the six- versus the five-item versions
were negligible. Because this item has not been reported
as problematic in other studies, and as the model fit of
the six-item QOLIBRI-OS in the present study may be
considered as fair, future studies should confirm a prob-
lem with this particular item before considering its re-
moval. The problem with item 3 could be related to the
translation, which differs slightly from the Norwegian
CENTER-TBI version. Norwegian language don’t differenti-
ate between the terms “«feelings” and “«emotion”, hence
there was a minor problem in back-translation from
Norwegian to English. Therefore a Norwegian replication
study containing some changes in wording may be per-
formed, investigating whether the translation of the above
mentioned item is inaccurate.
Validity of the QOLIBRI-OS
Analysis of the a priori hypotheses confirmed construct
validity. All a priori hypothesis tests, apart from one hy-
potheses, showed correlations with the selected other
measures in the presumed directions and magnitude
(Table 2). The correlation between Physical condition
and SS-QOL sum mobility was moderate 0.44, though
hypothesised to be high.
The COSMIN criteria indicate that construct validity
can be supported if the concurrent correlations with
other criterion-related variables are in the magnitude
and direction hypothesized or predetermined by the
authors. The present results uniformly fulfilled the
COSMIN criteria [44]. The lowest correlation was ob-
served between the “satisfaction with physical condi-
tion” item and the EQ-5D “mobility” question; this
finding is not surprising, as the EQ-5D assesses walking
ability in isolation, thus overlooking upper arm func-
tion and general health [38]. The highest correlation
was observed in a negative relationship between item 3
on the QOLIBRI-OS, “satisfaction with feelings and
emotions”, and the HADS total score, which assesses
psychological distress [31]; this result is in accordance
with previous findings [50]. Emotions contribute sub-
stantially to HRQOL, and the high correlation between
the QOLIBRI-OS emotion item and mental distress
supported maintaining this item, even though the CFA
indicated that it might be potentially problematic.
Table 3 Psychometric properties of the QOLIBRI-OS in 125 participants post-stroke: missing, mean values, item-total correlations and
floor and ceiling effects. Test-retest reliability in 36 participants
Item
N = 125







QOL1: Physical condition 0 3.47 (1.02) 0.74 5.6
12.6
0.81
QOL2: Cognitive function 0 3.58 (1.06) 0.73 2.4
20.0
0.87
QOL3: Emotions 0.8 3.58 (1.08) 0.85 3.2
20.8
0.80
QOL4: Daily activities 1.6 3.75 (1.11) 0.78 4.0
28.8
0.91
QOL 5: Personal and, social life 0 3.62 (1.19) 0.83 7.2
24.8
0.75
QOL 6: Current life and, future prospects 0 3.50 (1.09) 0.88 6.4
17.6
0.84
QOLIBRI-OS sum score 0.4 3.58 (0.93) 0.8
7.2
0.93
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Score reliability as test-retest stability
The ICC was tested using both consistency and agree-
ment methods. The results were nearly identical, indicat-
ing that the subjects provided rather identical responses.
The test-retest stability was particularly high for the
overall scale (ICC = 0.93), which is higher than in previ-
ously published studies (ICC = 0.81) [22]. This may re-
late to differences in time periods of assessment. In our
study, all participants performed test-retest at 12 months,
whereas in former studies of QOLIBRI-OS, test-retest
was investigated from 3 months to 15 years post stro-
ke.The test-retest stability of all single items were com-
parable excellent.
Summarized, the psychometric results of the
QOLIBRI-OS administered after stroke in this study are
comparable or better than the results determined after
TBI and subarachnoid haemorrhage [22, 24].
Can single items be considered individual domains?
The literature is ambiguous about the use of single items
[51] to assess HRQOL, as single items are less reliable
and valid than sum scores. Nevertheless, other scholars
have reported that the reliability of global questions re-
garding HRQOL might be adequate [52–54].
The EQ-5D [36] has scoring options that include the use
of single items. In our study, all of the QOLIBRI-OS items
appeared to be uniformly consistent. Means, item-total cor-
relations and test-retest stability varied slightly between
items and differed slightly from the results of the total
QOLIBRI-OS scale. Moreover, the concurrent validity coef-
ficients of the individual items were high, given the high
correlations with criterion-related measures, such as the
HADS and SS-QOL. A higher ceiling effect for single items
compared to the total score can be expected because of
more variation within sum scores. More patients after
stroke are expected to have optimal function in one specific
aspect assessed by the QOLIBRI-OS, than in all aspects.
Use of QOLIBRI-OS in patients after stroke?
For clinical and research purposes after stroke there is
no single preferred choice of outcome measure yet [4].
We performed a literature search in PubMed from 2014
to 2016 and discovered that the MRS was by far the
most commonly used outcome measure in stroke re-
search studies published from 2014 to 2016. However,
the MRS does not assess the patients’ subjective perspec-
tives of their health and wellbeing and is unable to dif-
ferentiate between physical and cognitive sequelae,
which is an important argument for including a patient
reported outcome measure (PROM).
However, can the QOLIBRI-OS, which is a brief meas-
ure, collect substantial information about important
HRQOL domains for patients after stroke? In our opin-
ion, the QOLIBRI-OS assesses the major consequences
of stroke. Compared to the SIS [55] the QOLIBRI-OS
contains one item measuring satisfaction with physical
condition but lacks detailed measurements of strength
and hand function. The SS-QOL which has 49 items,
also includes domains that assess vision and energy [14].
Both the SIS and SS-QOL address communication. The
lack of measurement of communication abilities (speak-
ing and understanding) presents, in our opinion, a weak-
ness of the QOLIBRI-OS for use post-stroke. The lack of
a specific communication component is likely due to the
fact that the instrument was developed only with gener-
alizing overall questions, and the communication aspect
was included in the overall item assessing cognition. In
addition, motor activity was assumed to be included in
the item assessing satisfaction with the physical condi-
tion. However, in stroke, communicative and motoric
problems are frequent specific problems [56]. Therefore,
we suggest that two additional new items should be de-
veloped and added to the QOLIBRI-OS- For instance,
an item from the QOLIBRI scale regarding satisfaction
with language and communicative skills and one item
assessing motor function could be included and the scale
should then be re-validated in a comprehensive stroke
population. For the time being, however, we recommend
the use of the QOLIBRI-OS in patients after stroke be-
cause it provides a short, reliable and valid index of
HRQOL after stroke.
Strengths and limitations of the study
The strengths of this study are that a major proportion of
the unselected stroke population admitted to UNN in
2014 is included. Patients were recruited from stroke units
and followed through early rehabilitation, in both hospital
and community settings. Of the consenting patients, 78%
responded to the main questionnaire, despite the broad
inclusion criteria and no exclusion of patients with aphasia
or cognitive problems. All patients responded during the
same time period post-stroke. The data quality was excel-
lent, and the results were consistent.
A significantly higher portion of non-responders was in-
stitutionalized. However, the absolute number of patients
with considerable functional deficits post-stroke was low
in both groups. A total of 14% of non-responders versus
7% of participants had MRS scores of 4 or 5. This finding
may limit the validity of the QOLIBRI-OS in the most se-
verely affected patients post-stroke. Due to Norwegian
ethical rules, comparisons between consenters and
non-participants are possible for the variables age and
gender only, which may limit the representativeness of the
results. Furthermore, this study did not evaluate respon-
siveness to change.
The sample size of 125 patients is less than the first
original multinational study of the validity of the
QOLIBRI-OS [22], which included 795 patients after
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TBI and thus provided more substantial statistical evi-
dence of the psychometric data quality. Our study is
consistent with the sample sizes from other validation
studies of HRQOL measures [18, 57].
Conclusions
The QOLIBRI-OS is a valid and reliable brief HRQOL
measure that is appropriate for application to patients
after stroke in research and clinical contexts.
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